This is unpublished

Mazyar
Shadman
M.D.
M.P.H.

he, him, his
Physician & Research Faculty
Pinned
Academic
Associate Professor, Clinical Research Division, Fred Hutchinson Cancer Research Center
Associate Professor, Division of Medical Oncology, University of Washington
Sites of Practice
Seattle Cancer Care Alliance
UW Medical Center - Montlake

Photo: SCCA

Education, Training, Board Certifications 

  • M.D., Tehran University of Medical Sciences, Iran 
  • M.P.H., University of Washington 
  • Residency, Cleveland Clinic 
  • Fellowship in Hematology-Oncology, UW 
  • Medical Oncology, American Board of Internal Medicine 
  • Hematology, American Board of Internal Medicine 
  • Internal Medicine, American Board of Internal Medicine 

Clinical Expertise  

  • Chronic lymphocytic leukemia 
  • Lymphoma and lymphoid malignancies 
  • Immunotherapy (CAR T-cell therapy) 
  • Hematopoietic stem cell transplantation 

Affiliations

Publications

Research and/or clinical interests 

Dr. Mazyar Shadman is a blood cancer specialist who focuses on lymphoid malignancies. He is involved in clinical research using novel therapeutic agents for lymphoma and chronic lymphocytic leukemia (CLL), as well as immunotherapy (specifically CAR T-cell therapy) for lymphoid neoplasms and blood stem cell transplant for hematologic malignancies. His goal is to identify the best treatment sequence or combination for patients with high-risk lymphoma and CLL.

Current research topics include:

  • Therapeutic clinical trials in lymphoid malignancies with a focus on CLL/SLL 
  • CAR T-cell therapy for lymphoma/CLL 
  • Clinical outcome research in lymphoid malignancies  
  • Epidemiology of hematologic malignancies